Sacral Neuromodulation System Market
Sacral Neuromodulation System Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Sacral Neuromodulation System Market Size and Growth
The Sacral Neuromodulation System market is experiencing significant growth, driven by increasing prevalence of urinary and bowel disorders. The market size is projected to reach approximately $1 billion by 2027, with advancements in technology and rising awareness of minimally invasive treatments. Key drivers include regulatory approvals and expanding healthcare access.
Companies Covered (Covid 19 Impact Covered)
◍ Medtronic, Inc. (US)
◍ Boston Scientific Corporation (US)
◍ St. Jude Medical, Inc. (US)
◍ Synapse Biomedical, Inc. (US)
◍ Nevro Corporation (US)
◍ Neurosigma, Inc. (US)
◍ Neuropace, Inc. (US)
◍ Neuronetics, Inc. (US)
◍ Cyberonics, Inc. (US)
◍ BioControl Medical (Israel)
The Sacral Neuromodulation System Market features key players like Medtronic and Boston Scientific, focusing on innovative technologies for urinary and fecal incontinence. Companies enhance market growth through product development and strategic partnerships.
- Medtronic: $30 billion (overall revenue)
- Boston Scientific: $11.7 billion
- Nevro Corporation: $266 million
Request Sample Report
Market Segmentation
By Application
◍ Spinal Cord Stimulation
◍ Deep Brain Stimulation
◍ Sacral Nerve Stimulation
◍ Vagus Nerve Stimulation
By Product
◍ Internal Neuromodulation System
◍ External Neuromodulation System
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
